ARE Patent Law Alert:USPTO GUIDANCE ON SUBJECT MATTER ELIGIBILITY OF METHOD OF TREATMENT CLAIMS

On April 13, 2018, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) affirmed the district court’s ruling that the claims at issue in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals, 887 F.3d 1117 (Fed. Cir. 2018), were patent eligible under 35 U.S.C. § 101. In a 2-1 split decision, the Court held that […]

In The Press:NYIPLA Participates in 2018 PTAB Judicial Conference in Alexandria, Virginia

On June 28, 2018, the USPTO hosted its 2018 PTAB Judicial Conference in Alexandria, Virginia. This was the first in a series of Judicial Conferences being hosted throughout the country. The NYIPLA was honored to participate in the conference with Charley Macedo, from Amster, Rothstein & Ebenstein LLP, co-chair of the newly created PTAB Committee […]